VTRS vs ZBH — Key Metrics
| Metric | VTRS (VIATRIS INC) | ZBH (ZIMMER BIOMET HOLDINGS INC) |
|---|---|---|
| Price | 20.28 | 103.32 |
| Market Cap | 23.25 Billion | 19.55 Billion |
| P/E (TTM) | -38.26 | 26.03 |
| P/B (Quarterly) | 1.589 | 1.639 |
| P/S (TTM) | 1.58 | 2.28 |
| Net Profit Margin (TTM) | -4.1 | 9.0 |
| Gross Margin (TTM) | 35.3 | 69.7 |
| ROE (TTM) | -4.2 | 6.1 |
| Revenue Growth YoY (TTM) | n/a | n/a |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
Greatly Outperform
Underperform
Recommendation Summary
Stock VTRS is projected to greatly outperform the market, stock ZBH is projected to underperform the market. Upfront Recommendation: VTRS.
Financial Metrics
| VTRS | Metrics | ZBH |
|---|---|---|
| $20.28 | Price | $103.32 |
| — | Market Capitalization | — |
| 1.58 | Price to Sales | 2.28 |
| 10.85 | Price to FCF Ratio | 15.1 |
| 4.47 | Price to Gross Profit | 3.27 |
| 23.17 | Price to R&D | 45.18 |
| 2.26 | Price to Current Assets | 3.81 |
VTRS vs ZBH at a glance
Viatris INC (VTRS) and Zimmer Biomet Holdings INC (ZBH) are both in the Healthcare sector. VTRS is the larger, at $23.3 billion in market value against $19.6 billion for ZBH, about 1.2 times the size.
On trailing-twelve-month figures, VTRS trades at 1.6 times trailing sales and ZBH at 2.3; net profit margins are -4.1% and 9.0%.
The Upfront Investment model currently rates VTRS Greatly Outperform and ZBH Underperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.